No Data
No Data
Trending Stocks Today: Smartsheet Gets a 11.85% Boost Post-Market
June 5th - US stocks trending post-market.Gainers: $Smartsheet(SMAR.US)$ jumps 11.85% to $42.26 with a turnover of $13.32 million. $Lululemon Athletica(LULU.US)$ rises 10.5% to $340.65 with a turnover
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
WALTHAM, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Goldman Sachs 45th Annual Global Heal
Stifel Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Announces Target Price $84
Stifel analyst Annabel Samimy maintains $Apellis Pharmaceuticals(APLS.US)$ with a buy rating, and sets the target price at $84.According to TipRanks data, the analyst has a success rate of 45.5% and a
Apellis Pharmaceuticals Initiated at Neutral by Piper Sandler
Apellis Pharmaceuticals Initiated at Neutral by Piper Sandler
Express News | Piper Sandler Initiates Coverage On Apellis Pharmaceuticals With Neutral Rating, Announces Price Target of $46
Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) Share Price Not Quite Adding Up
It's not a stretch to say that Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) price-to-sales (or "P/S") ratio of 9.5x right now seems quite "middle-of-the-road" for companies in the Biotechs industry
No Data